Apathy in amyotrophic lateral sclerosis: systematic review and meta-analysis of frequency, correlates, and outcomes

References

• Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377:942–55.
   PubMed Web of Science ®Google Scholar
• Kiernan MC, Vucic S, Talbot K, McDermott CJ, Hardiman O, Shefner JM, et al. Improving clinical trial outcomes in amyotrophic lateral sclerosis. Nat Rev Neurol. 2021;17:104–18.
   PubMed Web of Science ®Google Scholar
• Ahmed RM, Devenney EM, Irish M, Ittner A, Naismith S, Ittner LM, et al. Neuronal network disintegration: common pathways linking neurodegenerative diseases. J Neurol Neurosurg Psychiatry. 2016;87:1234–41.
   PubMed Web of Science ®Google Scholar
• Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein LH, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:131–46.
   PubMed Web of Science ®Google Scholar
• Huynh W, Ahmed R, Mahoney CJ, Nguyen C, Tu S, Caga J, et al. The impact of cognitive and behavioral impairment in amyotrophic lateral sclerosis. Expert Rev Neurother. 2020;20:281–93.
   PubMed Web of Science ®Google Scholar
• Robert P, Lanctôt KL, Agüera-Ortiz L, Aalten P, Bremond F, Defrancesco M, et al. Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 International Consensus Group. Eur Psychiatry. 2018;54:71–6.
   PubMed Web of Science ®Google Scholar
• Leung DKY, Chan WC, Spector A, Wong GHY. Prevalence of depression, anxiety, and apathy symptoms across dementia stages: a systematic review and meta-analysis. Int J Geriatr Psychiatry. 2021;36:1330–44.
   PubMed Web of Science ®Google Scholar
• Le Heron C, Holroyd CB, Salamone J, Husain M. Brain mechanisms underlying apathy. J Neurol Neurosurg Psychiatry. 2019;90:302–12.
   PubMed Web of Science ®Google Scholar
• Grossman AB, Woolley-Levine S, Bradley WG, Miller RG. Detecting neurobehavioral changes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8:56–61.
   PubMed Web of Science ®Google Scholar
• Chiò A, Vignola A, Mastro E, Giudici AD, Iazzolino B, Calvo A, et al. Neurobehavioral symptoms in ALS are negatively related to caregivers' burden and quality of life. Eur J Neurol. 2010;17:1298–303.
   PubMed Web of Science ®Google Scholar
• Radakovic R, Stephenson L, Newton J, Crockford C, Swingler R, Chandran S, et al. Multidimensional apathy and executive dysfunction in amyotrophic lateral sclerosis. Cortex. 2017;94:142–51.
   PubMed Web of Science ®Google Scholar
• Witgert M, Salamone AR, Strutt AM, Jawaid A, Massman PJ, Bradshaw M, et al. Frontal-lobe mediated behavioral dysfunction in amyotrophic lateral sclerosis. Eur J Neurol. 2010;17:103–10.
   PubMed Web of Science ®Google Scholar
• Terada T, Obi T, Yoshizumi M, Murai T, Miyajima H, Mizoguchi K. Frontal lobe-mediated behavioral changes in amyotrophic lateral sclerosis: are they independent of physical disabilities? J Neurol Sci. 2011;309:136–40.
   PubMed Web of Science ®Google Scholar
• Olney RK, Murphy J, Forshew D, Garwood E, Miller BL, Langmore S, et al. The effects of executive and behavioral dysfunction on the course of ALS. Neurology. 2005;65:1774–7.
   PubMed Web of Science ®Google Scholar
• Hu WT, Shelnutt M, Wilson A, Yarab N, Kelly C, Grossman M, et al. Behavior matters—cognitive predictors of survival in amyotrophic lateral sclerosis. PLOS One. 2013;8:e57584.
   PubMed Web of Science ®Google Scholar
• Elamin M, Phukan J, Bede P, Jordan N, Byrne S, Pender N, et al. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology. 2011;76:1263–9.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Prev Med. 2007;45:247–51.
   PubMed Web of Science ®Google Scholar
• Palmer TM, Sterne JAC. Meta-analysis in Stata: an updated collection from the Stata journal. Stata Press; 2016.
   Google Scholar
• de Alcântara C, Cruzeiro MM, França MC, Jr, Camargos ST, de Souza LC. Amyotrophic lateral sclerosis type 8 is not a pure motor disease: evidence from a neuropsychological and behavioural study. J Neurol. 2019;266:1980–7.
   PubMed Web of Science ®Google Scholar
• Andrews SC, Pavlis A, Staios M, Fisher F. Which behaviours? Identifying the most common and burdensome behaviour changes in amyotrophic lateral sclerosis. Psychol Health Med. 2017;22:483–92.
   PubMed Web of Science ®Google Scholar
• Bock M, Duong YN, Kim A, Allen I, Murphy J, Lomen-Hoerth C. Cognitive-behavioral changes in amyotrophic lateral sclerosis: screening prevalence and impact on patients and caregivers. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:366–73.
   PubMed Web of Science ®Google Scholar
• Branco LMT, Zanao TA, de Rezende T JR, Paraguay IBB, Leoni TB, Balthazar MLF, FranÇa MC Jr. Behavioral manifestations in a Brazilian non-demented C9orf72-negative ALS population. Amyotroph Lateral Scler Frontotemporal Degener. 2020 Feb;21(1-2):100–106.
   Google Scholar
• Burke T, Pinto-Grau M, Lonergan K, Bede P, O'Sullivan M, Heverin M, et al. A cross-sectional population-based investigation into behavioral change in amyotrophic lateral sclerosis: subphenotypes, staging, cognitive predictors, and survival. Ann Clin Transl Neurol. 2017;4:305–17.
   PubMed Web of Science ®Google Scholar
• Burke T, Elamin M, Galvin M, Gallagher L, Hardiman O, Pender N. Caregiver burden in amyotrophic lateral sclerosis: a cross-sectional investigation of predictors. J Neurol. 2015;262:1526–32.
   PubMed Web of Science ®Google Scholar
• Caga J, Turner MR, Hsieh S, Ahmed RM, Devenney E, Ramsey E, et al. Apathy is associated with poor prognosis in amyotrophic lateral sclerosis. Eur J Neurol. 2016;23:891–7.
   PubMed Web of Science ®Google Scholar
• Canosa A, Vacchiano V, D'Ovidio F, Calvo A, Moglia C, Manera U, et al. Brain metabolic correlates of apathy in amyotrophic lateral sclerosis: an 18F-FDG-positron emission tomography study. Eur J Neurol. 2021;28:745–53.
   PubMed Web of Science ®Google Scholar
• Consonni M, Cappa SF, Dalla Bella E, Contarino VE, Lauria G. Cortical correlates of behavioural change in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2019;90:380–6.
   PubMed Web of Science ®Google Scholar
• Cui B, Cui LY, Liu MS, Li XG, Ma JF, Fang J, et al. Behavioral symptoms in motor neuron disease and their negative impact on caregiver burden. Chin Med J. 2015;128:2295–300.
   PubMed Web of Science ®Google Scholar
• Femiano C, Trojsi F, Caiazzo G, Siciliano M, Passaniti C, Russo A, et al. Apathy is correlated with widespread diffusion tensor imaging (DTI) impairment in amyotrophic lateral sclerosis. Behav Neurol. 2018;2018:1–10.
   Web of Science ®Google Scholar
• Girardi A, MacPherson SE, Abrahams S. Deficits in emotional and social cognition in amyotrophic lateral sclerosis. Neuropsychology. 2011;25:53–65.
   PubMed Web of Science ®Google Scholar
• Kasper E, Schuster C, Machts J, Bittner D, Vielhaber S, Benecke R, et al. Dysexecutive functioning in ALS patients and its clinical implications. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:160–71.
   PubMed Web of Science ®Google Scholar
• Lillo P, Mioshi E, Zoing MC, Kiernan MC, Hodges JR. How common are behavioural changes in amyotrophic lateral sclerosis? Amyotroph Lateral Scler. 2011;12:45–51.
   PubMed Web of Science ®Google Scholar
• Machts J, Loewe K, Kaufmann J, Jakubiczka S, Abdulla S, Petri S, et al. Basal ganglia pathology in ALS is associated with neuropsychological deficits. Neurology. 2015;85:1301–9.
   PubMed Web of Science ®Google Scholar
• McHutchison CA, Leighton DJ, McIntosh A, Cleary E, Warner J, Porteous M, et al. Relationship between neuropsychiatric disorders and cognitive and behavioural change in MND. J Neurol Neurosurg Psychiatry. 2020;91:245–53.
   PubMed Web of Science ®Google Scholar
• Mioshi E, Hsieh S, Caga J, Ramsey E, Chen K, Lillo P, Simon N, et al. A novel tool to detect behavioural symptoms in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:298–304.
   PubMed Web of Science ®Google Scholar
• Martins AP, Prado LGR, Lillo P, Mioshi E, Teixeira AL, de Souza LC. Deficits in emotion recognition as markers of frontal behavioral dysfunction in amyotrophic lateral sclerosis. J Neuropsychiatry Clin Neurosci. 2019;31:165–9.
   PubMed Web of Science ®Google Scholar
• Poletti B, Solca F, Carelli L, Faini A, Madotto F, Lafronza A, et al. Cognitive-behavioral longitudinal assessment in ALS: the Italian Edinburgh Cognitive and Behavioral ALS Screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:387–95.
   PubMed Web of Science ®Google Scholar
• Radakovic R, Gray D, Dudley K, Mioshi E, Dick D, Melchiorre G, et al. Reliability and validity of the brief Dimensional Apathy Scale. Arch Clin Neuropsychol. 2020;35:539–44.
   PubMed Web of Science ®Google Scholar
• Santangelo G, Siciliano M, Trojano L, Femiano C, Monsurrò MR, Tedeschi G, et al. Apathy in amyotrophic lateral sclerosis: insights from Dimensional Apathy Scale. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:434–42.
   PubMed Web of Science ®Google Scholar
• Siciliano M, Trojano L, Trojsi F, Monsurrò MR, Tedeschi G, Santangelo G. Assessing anxiety and its correlates in amyotrophic lateral sclerosis: the state-trait anxiety inventory. Muscle Nerve. 2019;60:47–55.
   PubMed Web of Science ®Google Scholar
• Tsujimoto M, Senda J, Ishihara T, Niimi Y, Kawai Y, Atsuta N, et al. Behavioral changes in early ALS correlate with voxel-based morphometry and diffusion tensor imaging. J Neurol Sci. 2011;307:34–40.
   PubMed Web of Science ®Google Scholar
• Watermeyer TJ, Brown RG, Sidle KC, Oliver DJ, Allen C, Karlsson J, et al. Impact of disease, cognitive and behavioural factors on caregiver outcome in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:316–23.
   PubMed Web of Science ®Google Scholar
• Wei Q, Chen X, Zheng Z, Huang R, Guo X, Cao B, et al. Frontal lobe function and behavioral changes in amyotrophic lateral sclerosis: a study from Southwest China. J Neurol. 2014;261:2393–400.
   PubMed Web of Science ®Google Scholar
• Wicks P, Abrahams S, Papps B, Al-Chalabi A, Shaw CE, Leigh PN, et al. SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis. J Neurol. 2009;256:234–41.
   PubMed Web of Science ®Google Scholar
• Woolley SC, Zhang Y, Schuff N, Weiner MW, Katz JS. Neuroanatomical correlates of apathy in ALS using 4 Tesla diffusion tensor MRI. Amyotroph Lateral Scler. 2011;12:52–8.
   PubMed Web of Science ®Google Scholar
• Caga J, Hsieh S, Highton-Williamson E, Zoing MC, Ramsey E, Devenney E, et al. Apathy and its impact on patient outcome in amyotrophic lateral sclerosis. J Neurol. 2018;265:187–93.
   PubMed Web of Science ®Google Scholar
• Caga J, Hsieh S, Highton-Williamson E, Zoing MC, Ramsey E, Devenney E, et al. The burden of apathy for caregivers of patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:599–605.
   PubMed Web of Science ®Google Scholar
• Unglik J, Bungener C, Delgadillo D, Salachas F, Pradat PF, Bruneteau G, et al. Emotional feeling in patients suffering from amyotrophic lateral sclerosis. Geriatr Psychol Neuropsychiatr Vieil. 2018;16:414–22.
   PubMed Web of Science ®Google Scholar
• Poletti B, Solca F, Carelli L, Madotto F, Lafronza A, Faini A, et al. The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:489–98.
   PubMed Web of Science ®Google Scholar
• Lulé D, Burkhardt C, Abdulla S, Böhm S, Kollewe K, Uttner I, et al. The Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen: a cross-sectional comparison of established screening tools in a German-Swiss population. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:16–23.
   PubMed Web of Science ®Google Scholar
• Crockford C, Newton J, Lonergan K, Chiwera T, Booth T, Chandran S, et al. ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology. 2018;91:e1370–e80.
   PubMed Web of Science ®Google Scholar
• Kourtesis P, Christidi F, Margioti E, Demenega C, Rentzos M, Evdokimidis I, et al. The Edinburgh Cognitive and Behavioral Amyotrophic Lateral Sclerosis Screen (ECAS): sensitivity in differentiating between ALS and Alzheimer's disease in a Greek population. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:78–85.
   PubMed Web of Science ®Google Scholar
• Radakovic R, Stephenson L, Colville S, Swingler R, Chandran S, Abrahams S. Multidimensional apathy in ALS: validation of the Dimensional Apathy Scale. J Neurol Neurosurg Psychiatry. 2016;87:663–9.
   PubMed Web of Science ®Google Scholar
• Abrahams S, Newton J, Niven E, Foley J, Bak TH. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:9–14.
   PubMed Web of Science ®Google Scholar
• Salas T, Radakovic R, Rodriguez-Castillo V, Marín S, Chaverri D, Rodriguez-Santos F. Spanish adaptation of the Dimensional Apathy Scale (DAS) in amyotrophic lateral sclerosis. Front Neurol. 2020;11:562837.
   PubMed Web of Science ®Google Scholar
• Turon-Sans J, Gascon-Bayarri J, Reñé R, Rico I, Gámez C, Paipa A, et al. Cognitive impairment in ALS patients and validation of the Spanish version of the ALS-CBS test. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:221–7.
   PubMed Web of Science ®Google Scholar
• Burkhardt C, Neuwirth C, Weber M. Longitudinal assessment of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): lack of practice effect in ALS patients? Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:202–9.
   PubMed Web of Science ®Google Scholar
• Ye S, Ji Y, Li C, He J, Liu X, Fan D. The Edinburgh Cognitive and Behavioural ALS Screen in a Chinese amyotrophic lateral sclerosis population. PLoS One. 2016;11:e0155496.
   PubMed Web of Science ®Google Scholar
• Vázquez-Costa JF, Carratalà-Boscà S, Tembl JI, Fornés-Ferrer V, Pérez-Tur J, Martí-Bonmatí L, et al. The width of the third ventricle associates with cognition and behaviour in motor neuron disease. Acta Neurol Scand. 2019;139:118–27.
   PubMed Web of Science ®Google Scholar
• Murphy J, Factor-Litvak P, Goetz R, Lomen-Hoerth C, Nagy PL, Hupf J, et al. Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort. Neurology. 2016;86:813–20.
   PubMed Web of Science ®Google Scholar
• Flaherty-Craig C, Brothers A, Dearman B, Eslinger P, Simmons Z. Penn State screen exam for the detection of frontal and temporal dysfunction syndromes: application to ALS. Amyotroph Lateral Scler. 2009;10:107–12.
   PubMed Web of Science ®Google Scholar
• Ohta Y, Sato K, Takemoto M, Takahashi Y, Morihara R, Nakano Y, et al. Behavioral and affective features of amyotrophic lateral sclerosis patients. J Neurol Sci. 2017;381:119–25.
   PubMed Web of Science ®Google Scholar
• Woolley SC, Moore DH, Katz JS. Insight in ALS: awareness of behavioral change in patients with and without FTD. Amyotroph Lateral Scler. 2010;11:52–6.
   PubMed Web of Science ®Google Scholar
• Ye S, Rosenbohm A, Böhm S, Uttner I, Ji Y, Ludolph AC, et al. Cognitive and behavioral impairments in German and Chinese ALS populations – a post-hoc comparison of national study data. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:28–36.
   PubMed Web of Science ®Google Scholar
• Lansdall CJ, Coyle-Gilchrist ITS, Vázquez Rodríguez P, Wilcox A, Wehmann E, Robbins TW, et al. Prognostic importance of apathy in syndromes associated with frontotemporal lobar degeneration. Neurology. 2019;92:e1547–e57.
   PubMed Web of Science ®Google Scholar
• Salah AB, Pradat PF, Villain M, Balcerac A, Pradat-Diehl P, Salachas F, et al. Anosognosia in amyotrophic lateral sclerosis: a cross-sectional study of 85 individuals and their relatives. Ann Phys Rehabil Med. 2021;64:101440.
   PubMed Web of Science ®Google Scholar
• Veasey SC, Davis CW, Fenik P, Zhan G, Hsu YJ, Pratico D, et al. Long-term intermittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleep–wake brain regions. Sleep. 2004;27:194–201.
   PubMed Web of Science ®Google Scholar
• Caga J, Tu S, Dharmadasa T, Tse NY, Zoing MC, Huynh W, et al. Apathy is associated with parietal cortical-subcortical dysfunction in ALS. Cortex. 2021;145:341–9.
   PubMed Web of Science ®Google Scholar
• Pagonabarraga J, Kulisevsky J, Strafella AP, Krack P. Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment. Lancet Neurol. 2015;14:518–31.
   PubMed Web of Science ®Google Scholar
• Zou ZY, Li XG, Liu MS, Cui LY. Screening for C9orf72 repeat expansions in Chinese amyotrophic lateral sclerosis patients. Neurobiol Aging. 2013;34:1710.e5–1710.e6.
   PubMed Web of Science ®Google Scholar
• Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000. J Neurol Neurosurg Psychiatry. 2003;74:1258–61.
   PubMed Web of Science ®Google Scholar
• Van den Berg JP, Kalmijn S, Lindeman E, Veldink JH, de Visser M, Van der Graaff MM, et al. Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology. 2005;65:1264–7.
   PubMed Web of Science ®Google Scholar